Watch this on-demand webinar to find out more about the advantages and challenges of adopting 3D cell culturing
3D cell culture techniques have continued to receive attention, with many scientists curious about if it is now time to start transitioning from 2D to complete 3D cell culture techniques. 3D models hold remarkable promise for disease modeling, with the potential to help study tissue repair and drug responses.
In this on-demand SelectScience webinar, Carl Radosevich, Senior Manager, Scientific Applications and Collaborations, PHCbi, incubation product specialist, Holly Hattaway, also of PHCbi, and Jin Akagi, CEO of On-chip Biotechnologies explore the advances in 3D cell culturing for spheroids, compare 2D and 3D methods and their respective results, and discuss the options available to overcome the limitations associated with spheroid development. Also, find out how to enhance your research capabilities through safer cell sorting, uniquely designed 3D culturing vehicles and smart controls in incubation decontamination methodology.
Read on for highlights from the Q&A discussion at the end of the live webinar or register to watch the full webinar on demand>>
HH: The dual IR sensor enables the incubator to read CO2 in real time and respond in real time. Dual sensors allow you to have one that's self-calibrating to make sure that it's reading CO2 levels properly and it's not affected by any events like a door opening. Regardless of humidity and temperature, the CO2 should be brought back up in real time.
JA: Unfortunately, the dispenser itself doesn't have a fluorescence detector, it uses the brightfield camera to detect whether there is a cell or not. It can determine the size of the spheroid or the cell and it dispenses according to the sizes or the number that's been aspirated into the pipette tip. We designed it in a way where the purification steps will be involved before doing the distinction. For example, using our cell sorter to purify the sample.
JA: No, the instrument is unique in the way that you get to choose whatever media you'd like to use to sort your samples, including the spheroid. People often use culture medium to have optimal conditions. Your cells will be happy all the way from when you put it in, to when they come out. That's a unique feature of our instrument that is not something that's attainable using other conventional systems.
HH: That sounds like a question about oxygen-controlled incubators. When it comes to testing in conditions that have limiting factors involved, especially in cancer research and stem cell research, they've found that physiological oxygen levels are much lower than the levels of oxygen that are received in the incubator, (which is atmospheric, about 21%). This creates a hypoxic environment for cells. It doesn't necessarily hold true to in vivo environments. And by producing this more physiologically relevant environment, you can have more significantly in vivo-like results.
When you're dealing with a 3D spheroid cellular culture, you end up seeing these gradients of gases and oxygen. When you're considering the efficacy of drugs, you must consider the oxygen levels that are actually presented in vivo. There is a lot of research that is turning towards oxygen levels representing more physiologically relevant levels like about 5%, because that better represents the oxygen level that gets to the actual tissue in vivo.
HH: In the research I've found that addresses spheroid growth, they didn't report having to use extra antibodies or cytokines, and it could be dependent on your research. The most recent studies concerning stem cells, it's protocol specific, but they haven't needed to add anything. I have read some studies comparing the Matrigel to the 3D spheroid with the low-adhesion plates, they found that there's less intrusive signaling, there's less unwanted signaling from the biologically derived Matrigel. In the protocol, they haven't had to add any additional cytokines comparing it to a scaffolding type of 3D culture.
HH: Research using prime service plates specifically, they haven't needed to add any specific things like that for their culture. That's part of the reason the ULA plates, or the ultra-low attachment plates have been considered one of the easier ways to implement 3D culture in laboratory settings because you don't find these extra hormones or extra markers that need to be added necessarily that don't adhere to your normal protocol.
HH: We have a specialized formula of the H2O2 decontaminant that has been perfected for use in the square footing and the machinery of the incubator. It's enabled us to make it so that the sensors and everything in there just stays in place, but it's perfected under our H2O2 solution. Unfortunately, we cannot guarantee the same results using anything other than ours.
HH: All the well shapes have produced great optical clarity for experiments. What it depends on is what your culture seems to do the best in, and the attractiveness of these plates is that you don't have to transfer it to a different type of well shape, there's no transfer step needed. They all provide optical clarity and I haven't heard any specification for one of the shapes as far as optical clarity is concerned.
JA: The minimum is as low as 20 microliters and that's a lot smaller than many of the other instruments. The maximum will be one milliliter at a time. You can always continue to load more and more; you can carry on and keep on loading by stopping the run each time. In one single run, if you do not want to stop, one milliliter is the maximum.
JA: In some cases, people would like to culture 3D spheroids put them back into the body in these cases you would. In other cases, we like to simply culture them. We do recommend having them inside a biocontainment cabinet or a biosafety cabinet to keep them nice and clean, and if something happens, you can have everything contained. It depends on what kind of downstream application people would like to test.
JA: No, we do not have the concept of the nozzle anymore, because what we have is a continuous flow of liquid through a channel. Clogging could potentially happen at the intersection where we do all of our sorting, but we usually don't see them. If it does happen because the sample has something very gooey there or you get dust in there, we have a way to de-clog this easily. It's not like the conventional sorting process, where it has a nozzle and then the clog is a big issue.
Find out more about the latest advances in 3D cell culturing for spheroids: Watch this webinar on demand>>
Follow this link:
Webinar on benefits of 3D cell culture techniques - SelectScience
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments